190 related articles for article (PubMed ID: 36000252)
1. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Curr Med Res Opin; 2022 Nov; 38(11):1947-1957. PubMed ID: 36000252
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Clin J Pain; 2023 Mar; 39(3):107-118. PubMed ID: 36728675
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
5. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Pain Med; 2024 Mar; 25(3):173-186. PubMed ID: 38243702
[TBL] [Abstract][Full Text] [Related]
6. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
7. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.
Weiner SG; Hendricks MA; El Ibrahimi S; Ritter GA; Hallvik SE; Hildebran C; Weiss RD; Boyer EW; Flores DP; Nelson LS; Kreiner PW; Fischer MA
PLoS One; 2022; 17(4):e0266561. PubMed ID: 35381052
[TBL] [Abstract][Full Text] [Related]
8. Individual short-acting opioids and the risk of opioid-related adverse events in adolescents.
Chung CP; Callahan ST; Cooper WO; Dupont WD; Murray KT; Franklin AD; Hall K; Dudley JA; Stein CM; Ray WA
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1448-1456. PubMed ID: 31418512
[TBL] [Abstract][Full Text] [Related]
9. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291
[TBL] [Abstract][Full Text] [Related]
10. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study.
Black JC; Margolin ZR; Olson RA; Dart RC
JMIR Public Health Surveill; 2020 Jun; 6(2):e17073. PubMed ID: 32597786
[TBL] [Abstract][Full Text] [Related]
11. The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths.
Karami S; Ajao A; Wong J; Zhang D; Meyer T; Ding Y; Secora A; Major JM; Gill R; Chai GP; Zhao Y; McAninch J
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):735-751. PubMed ID: 36779261
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study.
Lundstrom EW; Dai Z; Groth CP; Hendricks B; Winstanley EL; Abate M; Smith GS
Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):4. PubMed ID: 38178238
[TBL] [Abstract][Full Text] [Related]
13. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
[TBL] [Abstract][Full Text] [Related]
14. Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.
Bigal LM; Bibeau K; Dumbar S
J Opioid Manag; 2019; 15(6):499-506. PubMed ID: 31850512
[TBL] [Abstract][Full Text] [Related]
15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of hydrocodone vs. oxycodone in primary care.
Harris RA; Kranzler HR; Chang KM; Doubeni CA; Gross R
Drug Alcohol Depend; 2019 Dec; 205():107524. PubMed ID: 31707268
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the abuse of tapentadol immediate release: the first 24 months.
Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
[TBL] [Abstract][Full Text] [Related]
19. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
20. Chronic use of tramadol after acute pain episode: cohort study.
Thiels CA; Habermann EB; Hooten WM; Jeffery MM
BMJ; 2019 May; 365():l1849. PubMed ID: 31088782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]